Logo

Immunotherapy

News and reporting on cancer immunotherapy.

UK Researchers Show Cytotoxic T-Cell Level Predicts Melanoma Immunotherapy Response

A Science Immunology paper details how patients with more cytotoxic effector T cells in peripheral blood at baseline respond better to checkpoint inhibitors.

T Cell Repertoire Emerging as Potential Predictor in Neoadjuvant Lung Cancer Immunotherapy
Premium

A Spanish team is hoping it can further validate promising early results using TCR characteristics to predict the success or failure of pre-surgery chemoimmunotherapy.

Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy

Leaders from collaborating Cleveland Clinic institutes will work with PGDx to optimize its ctDNA test reporting and adapt its technology for new oncology applications.

Clarified Precision Medicine Acquires Molecular Diagnostics Firm Interpares Biomedicine

The acquisition brings Interpares' genetic sequencing test, OncoGuardian, into Clarified's portfolio of precision medicine products.

Kiromic BioPharma Acquires InSilico Solutions

Kiromic expects the acquisition of the custom bioinformatics technology developer to facilitate new cancer immunotherapy discovery.

Jul 11, 2017

Neon Therapeutics' Personalized Vaccine Approach Progresses With Combination Immunotherapy Trial
Premium

Jul 10, 2017

CRISPR Therapeutics, Neon Therapeutics Enter Research Collaboration

Jun 15, 2017

PD-L2 Adds Value to Immunotherapy Prediction in Head and Neck Cancers, Merck Study Finds
Premium

Jun 8, 2017

MMR Deficiency Ties to Checkpoint Blockade Response Explored in Prospective Study

Jun 7, 2017

ASCO Presenter Proposes Gut Microbiome Profiling in Checkpoint Blockade Response Trials

Jun 5, 2017

Researchers Seeking Biomarkers for Immune-Related Adverse Events During Immunotherapy

Jun 5, 2017

Qiagen Inks Separate NGS Deals With Bristol-Myers Squibb, Johns Hopkins

May 26, 2017

Expanded Keytruda Approval Signals New Phase for Precision Medicine, May Benefit NGS Panel Makers
Premium

May 23, 2017

FDA Approves First Drug For Tumor's Biomarker Indication

May 11, 2017

Which PD-L1 Assay to Use With Which NSCLC Immunotherapy? There's an Atlas for That Now
Premium

Apr 19, 2017

Large Genomic Profiling Study Sees Mutation-Rich Tumors From Many Cancer Types

Apr 13, 2017

Cancer-Fighting T Cells Tuned To Viral Particles May Target Tumor Neoantigens

Apr 11, 2017

Illumina Partners With Human Vaccines Project

Apr 10, 2017

Cancer Genetics to Evaluate Biomarkers for Effector Therapeutics

Apr 7, 2017

Foundation Medicine Mining Clinical Sequencing Data for New Determinants of Immunotherapy Response
Premium

Mar 30, 2017

Foundation Medicine, Bristol-Myers Squibb Collaborate on Tumor Profiling

Mar 23, 2017

Qu Biologics Developing CDx for Immunomodulator Drug to Treat Inflammatory Bowel Disease
Premium

Mar 1, 2017

Metastatic Melanoma Study Highlights Genetics of Checkpoint Blockade Response

Feb 24, 2017

Non-Individualized Cancer Vaccines May Have Limited Applicability

Feb 13, 2017

Treos Bio Raises $8M in Private Funding Round

Breaking News
The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.